A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT01472198 · COMPLETED
Trial details
- NCT number
- NCT01472198
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.